NASDAQ: AADI

Aadi Bioscience, Inc.

Healthcare · Biotechnology

Market Cap

$94.89M

52w High

$3.81

52w Low

$1.21

P/E

-1.49

Volume

62.61K

Outstanding Shares

46.29M

Not enough data to analyse price vs. fundamentals for this ticker.

Company profile

Aadi Bioscience, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing highly targeted therapies for cancers defined by specific genetic alterations within the mTOR pathway.

CEODavid J. Lennon

SectorHealthcare

IndustryBiotechnology

Employees53

IPO dateFeb 16, 2018

https://aadibio.com

Valuation

Forward P/E—

EV/EBITDA-8.92

Enterprise value$1.02B

Stock splits

Aug 27, 2021↓ Reverse

Every 15 shares became 1

-93%

Aug 18, 2021↑ Forward

Every 1 shares became 2

+100%

Profitability & growth

Revenue growth-100%

Gross margin0%▼100.00%vs FY2024

Operating margin0%▼516.71%vs FY2024

ROE-15.11%▲87.55%vs FY2024

Analyst consensus

RatingBuy

Target price$1.63▼20.49%

Buy

Hold

Sell

Analyst ratings tend to be lagging indicators. Use as one signal among many.

Earnings

Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.

Next report

Mar 12, 2026

Q2 FY26 · EPS est — · Revenue est —

View